ENDOXAN Trademark

Trademark Overview

On Friday, February 22, 2008, a trademark application was filed for ENDOXAN with the United States Patent and Trademark Office. The USPTO has given the ENDOXAN trademark a serial number of 77403527. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 20, 2010. This trademark is owned by Baxter Heathcare S.A.. The ENDOXAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, cyclophosphamide used to treat cancer and autoimmune disorders
endoxan

General Information

Serial Number77403527
Word MarkENDOXAN
Filing DateFriday, February 22, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 20, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2009

Trademark Statements

Goods and ServicesPharmaceutical products, namely, cyclophosphamide used to treat cancer and autoimmune disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 28, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaxter Heathcare S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWallisellen CH8304
CH
Party NameBaxter Heathcare S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWallisellen CH8304
CH

Trademark Events

Event DateEvent Description
Monday, December 20, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 20, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 18, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 6, 2010NEW NOA TO ISSUE
Tuesday, April 6, 2010NOTICE OF ALLOWANCE CANCELLED
Tuesday, April 6, 2010NOA MAILED - SOU REQUIRED FROM APPLICANT
Sunday, February 21, 2010NEW NOA TO ISSUE
Wednesday, December 2, 2009NOTICE OF ALLOWANCE CANCELLED
Sunday, February 21, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 26, 2010PETITION TO REVIVE-GRANTED
Tuesday, January 26, 2010TEAS PETITION TO REVIVE RECEIVED
Monday, January 4, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 4, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 2, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 10, 2009PUBLISHED FOR OPPOSITION
Wednesday, February 18, 2009NOTICE OF PUBLICATION
Saturday, January 31, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 30, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 27, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 27, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 21, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 22, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2008NON-FINAL ACTION E-MAILED
Tuesday, July 22, 2008NON-FINAL ACTION WRITTEN
Tuesday, July 22, 2008PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, June 23, 2008WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, June 9, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, June 7, 2008ASSIGNED TO LIE
Friday, June 6, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 4, 2008ASSIGNED TO EXAMINER
Thursday, February 28, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

endoxan cancer autoimmune disorders treat used products namely cyclophosphamide pharmaceutical